Mcg in 2030: new techniques for atomic position determination of immune complexes.

Hanson BL, Bunick GJ, Harp JM, Edmundson AB
J Mol Recognit. 2002 15 (5): 297-305

PMID: 12447907 · DOI:10.1002/jmr.591

The lambda-type light chain dimer from a patient (Mcg) with multiple myeloma and amyloidosis was a pioneer protein for determining the three-dimensional structures of immunoglobulins, understanding the effects of ligand binding, and exploring the use of combinatorial methods to identify novel peptides complementary to protein active sites. Despite 30 years of intense study, there are still unanswered questions about the structure of the Mcg dimer, especially with respect to positions of hydrogen atoms and solvent molecules. In the present report, we describe two techniques that will help define the roles of solvent in ligand interactions and complex formation with this immunoglobulin fragment: (1) introduction of helium as a cryogenic agent during X-ray data collection; and (2) addition of neutron diffraction analyses. These techniques should provide improved resolution, and a more accurate structure of the Mcg dimer. Resolution enhancements of 0.5 A have been achieved in preliminary experiments with cryogenic helium, as compared with the best X-ray diffraction data obtained previously. In the near future, neutron diffraction studies should produce the first hydrogen structure for the Mcg dimer and help elucidate the ligand preferences and amyloidogenic properties of this eminently useful protein.

Copyright 2002 John Wiley & Sons, Ltd.

MeSH Terms (16)

Amyloidosis Antigen-Antibody Complex Bence Jones Protein Crystallography, X-Ray Dimerization Freezing Helium Humans Immunoglobulin lambda-Chains Models, Molecular Molecular Structure Multiple Myeloma Neutron Diffraction Nitrogen Static Electricity Synchrotrons

Connections (1)

This publication is referenced by other Labnodes entities:

Links